WO2006131586B1 - Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención - Google Patents
Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtenciónInfo
- Publication number
- WO2006131586B1 WO2006131586B1 PCT/ES2006/070079 ES2006070079W WO2006131586B1 WO 2006131586 B1 WO2006131586 B1 WO 2006131586B1 ES 2006070079 W ES2006070079 W ES 2006070079W WO 2006131586 B1 WO2006131586 B1 WO 2006131586B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- bioactive
- peptides
- activity
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/921,797 US8354502B2 (en) | 2005-06-08 | 2006-06-08 | Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
EP06764378A EP1905779A4 (en) | 2005-06-08 | 2006-06-08 | IN ENZYMATIC HYDROLYSATES OF MILK CASEINS IDENTIFIED BIOLOGICAL ACTIVE PEPTIDES AND METHOD FOR THEIR RECOVERY |
BRPI0611729-5A BRPI0611729A2 (pt) | 2005-06-08 | 2006-06-08 | peptìdeo bioativo, método para produzir o mesmo, produto bioativo, composição farmacêutica, aditivo, ingrediente ou suplemento alimentìcio funcional, produto alimentìcio funcional, e utilização da composição farmacêutica |
MX2007015528A MX2007015528A (es) | 2005-06-08 | 2006-06-08 | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
JP2008515233A JP2008545774A (ja) | 2005-06-08 | 2006-06-08 | 乳カゼインの酵素的水解物中で同定される生物活性ペプチド及び該ペプチドの製造方法 |
AU2006256720A AU2006256720A1 (en) | 2005-06-08 | 2006-06-08 | Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
CN200680029333.0A CN101305017B (zh) | 2005-06-08 | 2006-06-08 | 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 |
CA2611416A CA2611416C (en) | 2005-06-08 | 2006-06-08 | Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method for the production thereof |
NO20080103A NO20080103L (no) | 2005-06-08 | 2008-01-07 | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse |
KR1020087000546A KR101343904B1 (ko) | 2005-06-08 | 2008-01-08 | 우유 카제인의 효소 가수분해물에서 식별된 생물활성펩티드 및 그것을 얻는 방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200501373A ES2319475B1 (es) | 2005-06-08 | 2005-06-08 | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
ESP200501373 | 2005-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006131586A1 WO2006131586A1 (es) | 2006-12-14 |
WO2006131586B1 true WO2006131586B1 (es) | 2007-02-01 |
Family
ID=37498152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/070079 WO2006131586A1 (es) | 2005-06-08 | 2006-06-08 | Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención |
Country Status (12)
Country | Link |
---|---|
US (1) | US8354502B2 (es) |
EP (2) | EP2495250A3 (es) |
JP (1) | JP2008545774A (es) |
KR (1) | KR101343904B1 (es) |
CN (2) | CN101305017B (es) |
AU (1) | AU2006256720A1 (es) |
BR (1) | BRPI0611729A2 (es) |
CA (1) | CA2611416C (es) |
ES (1) | ES2319475B1 (es) |
MX (1) | MX2007015528A (es) |
NO (1) | NO20080103L (es) |
WO (1) | WO2006131586A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10331202A1 (de) | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
BRPI0707042A2 (pt) * | 2006-03-24 | 2011-04-12 | Unilever Nv | produto alimentìcio e uso |
DE102006036285A1 (de) * | 2006-08-03 | 2008-02-07 | "S.U.K." Beteiligungs Gmbh | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
EP2253324A1 (en) * | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
WO2011105435A1 (ja) * | 2010-02-24 | 2011-09-01 | 森永乳業株式会社 | 摂食障害治療剤 |
CN103232526B (zh) * | 2012-12-12 | 2015-06-24 | 上海交通大学 | 一种生物活性多肽lplp及其制备和应用 |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
CN103616454B (zh) * | 2013-12-06 | 2015-06-03 | 贝因美婴童食品股份有限公司 | 一种定量检测人β-酪蛋白含量的方法以及试剂盒 |
CN104073539B (zh) * | 2014-06-17 | 2017-03-29 | 黑龙江省乳品工业技术开发中心 | 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用 |
JP2017048124A (ja) * | 2015-08-31 | 2017-03-09 | 森永乳業株式会社 | アミノペプチダーゼa阻害剤 |
EP3170507B1 (en) | 2015-11-20 | 2022-12-21 | Consejo Superior de Investigaciones Científicas (CSIC) | Antihypertensive peptides from olive oil |
CN107337710A (zh) * | 2017-07-26 | 2017-11-10 | 盐城卫生职业技术学院 | 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物 |
CN107814838A (zh) * | 2017-12-07 | 2018-03-20 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用 |
CN107880106B (zh) * | 2017-12-11 | 2020-06-16 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptlnre及其制备方法和应用 |
KR102073824B1 (ko) * | 2018-04-11 | 2020-02-05 | 강원대학교산학협력단 | 간 보호용 건강기능식품 및 이의 제조 방법 |
CN111574585B (zh) * | 2019-01-30 | 2021-10-01 | 浙江省医学科学院 | 一种鳕鱼皮寡肽及其分离纯化方法和应用 |
CN110498833B (zh) * | 2019-08-30 | 2021-01-15 | 华南理工大学 | 一种具有ace抑制作用的三肽及其应用 |
US11326176B2 (en) | 2019-11-22 | 2022-05-10 | Mozza Foods, Inc. | Recombinant micelle and method of in vivo assembly |
CN111777665B (zh) * | 2020-07-24 | 2022-07-05 | 北京林业大学 | 一种核桃粕抗氧化肽faw及其制备方法与应用 |
CN115505025A (zh) * | 2022-11-10 | 2022-12-23 | 东北农业大学 | 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选 |
CN116444608A (zh) * | 2022-11-30 | 2023-07-18 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽dpsffake及其制备方法与应用 |
CN116444619A (zh) * | 2022-11-30 | 2023-07-18 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽ypfpgpihnslp及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4444753C2 (de) * | 1994-12-15 | 1998-08-06 | Forssmann Wolf Georg | Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung |
US6060448A (en) * | 1995-10-31 | 2000-05-09 | Pepsyn Limited | Casein fragments having growth promoting activity |
AUPP051497A0 (en) | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
AU768673B2 (en) * | 1998-09-15 | 2003-12-18 | Nizo Food Research | Process for producing peptides from biological fluids and peptides obtainable by said process |
WO2001085984A1 (en) | 2000-05-08 | 2001-11-15 | Davisco Foods International, Inc. | Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
US6514941B1 (en) | 1999-12-10 | 2003-02-04 | Campina Melkunie B.V. | Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides |
IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
GB0016189D0 (en) * | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
US6465432B1 (en) | 2000-08-28 | 2002-10-15 | Kraft Food Holdings, Inc. | Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides |
CA2458924A1 (en) * | 2001-08-30 | 2003-03-06 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
WO2004089986A1 (en) | 2003-04-14 | 2004-10-21 | Stichting Voor De Technische Wetenschappen | Antimicrobial peptide from transferrin family |
-
2005
- 2005-06-08 ES ES200501373A patent/ES2319475B1/es active Active
-
2006
- 2006-06-08 CN CN200680029333.0A patent/CN101305017B/zh not_active Expired - Fee Related
- 2006-06-08 EP EP12158198.7A patent/EP2495250A3/en not_active Withdrawn
- 2006-06-08 CA CA2611416A patent/CA2611416C/en not_active Expired - Fee Related
- 2006-06-08 WO PCT/ES2006/070079 patent/WO2006131586A1/es active Application Filing
- 2006-06-08 CN CN201310023562.3A patent/CN103254278B/zh not_active Expired - Fee Related
- 2006-06-08 JP JP2008515233A patent/JP2008545774A/ja not_active Abandoned
- 2006-06-08 US US11/921,797 patent/US8354502B2/en not_active Expired - Fee Related
- 2006-06-08 AU AU2006256720A patent/AU2006256720A1/en not_active Abandoned
- 2006-06-08 EP EP06764378A patent/EP1905779A4/en not_active Withdrawn
- 2006-06-08 BR BRPI0611729-5A patent/BRPI0611729A2/pt not_active IP Right Cessation
- 2006-06-08 MX MX2007015528A patent/MX2007015528A/es not_active Application Discontinuation
-
2008
- 2008-01-07 NO NO20080103A patent/NO20080103L/no not_active Application Discontinuation
- 2008-01-08 KR KR1020087000546A patent/KR101343904B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN103254278B (zh) | 2015-07-22 |
BRPI0611729A2 (pt) | 2010-10-05 |
WO2006131586A1 (es) | 2006-12-14 |
ES2319475A1 (es) | 2009-05-07 |
EP2495250A2 (en) | 2012-09-05 |
CN103254278A (zh) | 2013-08-21 |
EP1905779A4 (en) | 2010-09-01 |
US8354502B2 (en) | 2013-01-15 |
EP1905779A1 (en) | 2008-04-02 |
CA2611416C (en) | 2015-10-06 |
CN101305017B (zh) | 2014-08-06 |
KR101343904B1 (ko) | 2013-12-23 |
ES2319475B1 (es) | 2010-02-16 |
MX2007015528A (es) | 2008-02-25 |
EP2495250A3 (en) | 2013-07-10 |
US20100048464A1 (en) | 2010-02-25 |
JP2008545774A (ja) | 2008-12-18 |
KR20080045108A (ko) | 2008-05-22 |
AU2006256720A1 (en) | 2006-12-14 |
NO20080103L (no) | 2008-03-04 |
CA2611416A1 (en) | 2006-12-14 |
CN101305017A (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006131586B1 (es) | Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención | |
JP2008545774A5 (es) | ||
Agyei et al. | Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities | |
López-Fandiño et al. | Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity | |
Korhonen | Milk-derived bioactive peptides: From science to applications | |
Pan et al. | Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004 | |
Cao et al. | Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats | |
Kamau et al. | Functional significance of bioactive peptides derived from milk proteins | |
María Hebert et al. | Bioactive peptides derived from casein and whey proteins | |
EP1568377A1 (en) | Cysteine protease inhibitor | |
CA3164332A1 (en) | Microorganism-derived protein hydrolysates, and methods of preparation and use thereof | |
Wu et al. | Simultaneous production of multi-functional peptides by pancreatic hydrolysis of bovine casein in an enzymatic membrane reactor via combinational chromatography | |
DE602004023210D1 (de) | Biologisch nicht-abbaubares peptid, inhibitor des angiotensinumwandelnden enzyms, arzneimittel und funktionelles nahrungsmittel | |
WO2005012355B1 (es) | Péptidos bioactivos derivados de proteínas de la clara de huevo mediante hidrólisis enzimática | |
Patil et al. | Bioactive peptides: Its production and potential role on health | |
Tagliazucchi et al. | Composition and properties of peptides that survive standardised in vitro gastro-pancreatic digestion of bovine milk | |
Bao et al. | Comparison of ACE inhibitory activity in skimmed goat and cow milk hydrolyzed by alcalase, flavourzyme, neutral protease and proteinase K | |
JP2004536030A (ja) | トリプトファンの豊富なペプチドの製造方法 | |
Abdelhedi et al. | Proteolysis coupled with membrane separation for the isolation of bioactive peptides from defatted smooth hound byproduct proteins | |
Kim et al. | Marine‐derived peptides: Development and health prospects | |
KR20130004284A (ko) | 단백질 합성 촉진제 | |
JP2003284551A (ja) | アンジオテンシンi変換酵素阻害剤 | |
Zeng et al. | ACE‐inhibitory Activities of Marine Proteins and Peptides | |
Ogori et al. | Food Derived Bioactive Peptides for Health Enhancement and Management of Some Chronic Diseases | |
Ortiz-Chao et al. | Enzymatic production of bioactive peptides from milk and whey proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680029333.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/015528 Country of ref document: MX Ref document number: 2611416 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008515233 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006256720 Country of ref document: AU Ref document number: 2006764378 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 564909 Country of ref document: NZ Ref document number: 92/KOLNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087000546 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008100025 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006256720 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006256720 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006764378 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11921797 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0611729 Country of ref document: BR Kind code of ref document: A2 |